Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Chemotherapy-related neurotoxicity is a frequently observed side effect that has become more prevalent with the increasing number of long-term cancer survivors. These toxicities can be peripheral or central and can range from minor cognitive issues to encephalopathy or dementia. Toxicities are often dose-limiting, resulting in dose reduction or treatment discontinuation, potentially compromising the therapeutic efficacy. This chapter will discuss the incidence, mechanism, symptoms, and management of chemotherapy-related neurotoxicity with a focus on the more common chemotherapeutic agents. The Common Terminology Criteria for Adverse Events (CTCAE) is widely used in the evaluation of chemotherapy-induced peripheral neuropathy. ( Table 7.1 ) Fig. 7.1 illustrates an algorithm for the evaluation and treatment of chemotherapy-related peripheral neuropathy.
Grade | Definition |
---|---|
1 | Asymptomatic; clinical or diagnostic observations only |
2 | Moderate symptoms; limiting instrumental ADL |
3 | Severe symptoms; limiting self-care ADL |
4 | Life-threatening consequences; urgent intervention indicated |
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here